Renowned skin cancer doctors Richard Scolyer and Georgina Long, who have previously made significant strides in melanoma treatment, are now turning their attention to an aggressive form of brain cancer. When Prof. Scolyer was diagnosed with a subtype of glioblastoma, the pair decided to apply their knowledge of melanoma treatment to his case. They used a combination of drugs and administered them before surgery, a method that had not been previously tested in brain cancer. The results have been promising, with Prof. Scolyer showing no signs of active cancer eight months post-surgery. While it is too early to confirm the effectiveness of this treatment, the initial results have sparked interest from pharmaceutical companies and discussions about clinical trials.
Not for human consumption
